CFIUS Disclosure

Caidya is the trade name of dMedClinical Co. Ltd. and its holdings. Clinipace, Inc. is one company in the Caidya group of companies. Clinipace, Inc. is owned, operated, managed, and controlled by dMedClinical Co. Ltd., a privately held company, whose investors include entities located in the People’s Republic of China (PRC), and which may be subject to PRC laws and regulations that differ from those of the United States. dMedClinical’s investor group are part of a best-in-class shareholder group which includes leading global venture capital and healthcare specialists.

Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

SCOPE EU

14th October 2025 to 15th October 2025
Barcelona, Spain

Outsourcing in Clinical Trials – New England

15th October 2025 to 16th October 2025
Boston Convention & Exhibition Center

09/19/2025

Caidya Appoints Dr. Bin Peng as Chair of its China Scientific Advisory Board

RALEIGH, N.C.; September 19, 2025 – Caidya, a leading global...
Skip to toolbar